Case 1: Should All Transplant-Eligible Patients Receive Early HDT and ASCT, or can Transplantation be Delayed in Some Cases?

Track: BMT Tandem "Scientific" Meeting
Saturday, February 14, 2015, 12:30 PM-1:30 PM
Seaport Ballroom ABC (Manchester Grand Hyatt)
Jeffrey L. Wolf, MD , Hematology, Blood and Marrow Transplant, University of California, San Francisco, San Francisco, CA
Audio File Recorded Presentation
Disclosures:
Nothing To Disclose
See more of: BMT Tandem Saturday Concurrent Luncheon Symposium: Management of Multiple Myeloma: A Case-Based Discussion of the Role of Transplantation in Improving Patient Outcomes
See more of: BMT Tandem "Scientific" Meeting
<< Previous Presentation | Next Presentation >>